pirfenidone has been researched along with Chronic Lung Injury in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Chen, C; Kang, M; Li, Z; Liao, S; Xu, B; Xue, D; Yang, Y; Zeng, B | 1 |
| Aoyama, J; Gemma, A; Kamio, K; Matsuda, K; Saito, Y; Seike, M; Tanaka, T | 1 |
| Hamidi, SH; Kadamboor Veethil, S | 1 |
| Chen, M; Chen, Y; Fang, M; Hang, QQ; Qian, X; Ying, H | 1 |
| Hasegawa, Y; Hashimoto, N; Ito, S; Sakamoto, K | 1 |
| Ghazi-Khansari, M; Heidari, MR; Iranpour, M; Mandegary, A; Pourgholamhossein, F; Pourgholi, L; Pournamdari, M; Poursalehi, HR; Rasooli, R; Samareh-Fekri, M | 1 |
| Chen-Yoshikawa, TF; Date, H; Masuda, S; Okabe, R; Saito, M; Suetsugu, K; Takahagi, A | 1 |
| Bacon, KB; Boehme, SA; DiTirro, DN; Franz-Bacon, K; Ly, TW | 1 |
1 review(s) available for pirfenidone and Chronic Lung Injury
| Article | Year |
|---|---|
Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; COVID-19; COVID-19 Drug Treatment; Humans; Inflammation; Lung Injury; Pyridones; SARS-CoV-2; Signal Transduction; Transforming Growth Factor beta | 2021 |
1 trial(s) available for pirfenidone and Chronic Lung Injury
| Article | Year |
|---|---|
Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial.
Topics: Clinical Trials, Phase II as Topic; Cytokines; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Lung Injury; Radiation Injuries; Randomized Controlled Trials as Topic | 2022 |
6 other study(ies) available for pirfenidone and Chronic Lung Injury
| Article | Year |
|---|---|
Increased CTGF expression in alveolar epithelial cells by cyclic mechanical stretch: Its mechanism and the therapeutic effect of pirfenidone.
Topics: Alveolar Epithelial Cells; Animals; Connective Tissue Growth Factor; Cytokines; Humans; Lung Injury; Mice; Mitogen-Activated Protein Kinase Kinases | 2023 |
Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway.
Topics: Animals; Bone Marrow Cells; Female; Fibrosis; Lung Injury; Macrophage Activation; Mice; Mice, Inbred C57BL; Pyridones; RAW 264.7 Cells; Smad3 Protein; Transforming Growth Factor beta1 | 2021 |
Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Biomarkers; Bleomycin; Humans; Lung Injury; Male; Middle Aged; Pyridones; Respiratory Function Tests; Seminoma; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Bronchoalveolar Lavage Fluid; Fibrosis; Gene Expression; Gene Expression Profiling; Herbicides; Hydroxyproline; Lung; Lung Injury; Male; Mice; Organ Size; Oxidative Stress; Paraquat; Pneumonia; Pulmonary Fibrosis; Pyridones; Reactive Oxygen Species; Transforming Growth Factor beta1 | 2018 |
Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Cytoprotection; Disease Models, Animal; Inflammation Mediators; Lung; Lung Injury; Lung Transplantation; Male; Pyridones; Rats, Wistar; Reperfusion Injury; Signal Transduction; Warm Ischemia | 2019 |
MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Topics: A549 Cells; Animals; Bleomycin; Bronchoalveolar Lavage; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Female; HeLa Cells; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Lung Injury; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Pyridones; Signal Transduction; Transforming Growth Factor beta; Up-Regulation | 2016 |